Healthcare Businesses for Sale and Investment Opportunities

- Beauty salon located in County Meath Ireland. - Top selling services include skin care treatments, advanced brows, facials, and nail treatments. - Database boasts over 4,000 clients, indicating a loyal localized customer base. - High-end, state-of-the-art salon featuring 5 treatment rooms, 3 nail stations, a brow bar, and a makeup station. - Established over 14 years with free on-street parking, enhancing accessibility for customers. - Annual turnover nearing €200,000, reflecting robust business performance. - Promoter possesses 24 years of industry experience, ensuring expertise and quality service. - Licensed incorporation, ensuring legal compliance and business legitimacy. - Current employee count is sufficient to manage operations effectively. - 5 star reviews. - Award winning salon.

- We have five in-house scientific projects: 1) An exosome-based delivery system for the transport, delivery, and localization of therapeutic molecules within the skin tumor microenvironment to treat human skin cancer. 2) The development of a confocal virtual reality (VR) 3-dimensional (3-D) immersive system for the diagnosis and analyses of human skin cancer tumors. 3) A skin cancer patient blockchain whereby skin cancer patients can set up smart contracts & receive payment for the use of their data from drug companies, research institutes, medical device companies, etc. 4) The utilization of ML and AI to visualize and analyze the resultant data from skin cancer subjects for the benefit of skin cancer patients, their family, and their healthcare providers. 5) The development of an in vitro toxicology system that uses human umbilical cord- and placental- derived mesenchymal stem cells, and cell lineages that may be derived from these, to serve as a developmental toxicological tool to reduce the number of animals use in preclinical drug research. - The company also works with pharmaceutical and diagnostic companies, research institutes, CROs, and CDMOs to help them develop molecular bioassays and digital pathology products, and to visualize and analyze the resultant data via AI and ML for the benefit of patients, their family, and their healthcare providers. - Currently, we have 3 clients: Klotho Therapeutics Inc. (a biotechnology company in San Diego, CA, USA), Unger Medical PC (a hair restoration medical practice in NY, NY, USA), and Astrix Technology Group (a life sciences strategy, technology, and staffing services company based in Red Bank, NJ, USA). • Target Market: - The business is specialized in developing diagnostics and therapeutics for human basal cell carcinoma, squamous cell carcinoma, and melanoma. This skin cancer group comprises the most diagnosed cancers worldwide of all cancer types with over five million cases diagnosed each year. - The skin cancer therapeutics diagnostics and therapeutics products industry worldwide were worth $8.2 billion USD in 2019 and is projected to reach $15 billion by 2027. This represents a CAGR of 7.5%. - What share of the total skin cancer target market is realistic for us to obtain? A conservative estimate is that our company should be able to reach $150 million USD in annual revenues by the close of 2028. • Problem or Need: - The main project involves the development of a Skin Cancer Patient Data Blockchain. - Currently there is a serious problem concerning how oncology patients organize and share their medical data, how companies get access to this data, and a lack of return in value to the patients for sharing their personal data. The blockchain is designed to tackle and solve these problems. - The blockchain for skin cancer patients will be comprised of multiple decentralized nodes contributing data to a shared ledger where patients can set up smart contracts to share and control their data. - Skin cancer patients will be able to share their data with research institutions, drug companies, diagnostic companies, contract research organizations, client trials organizers, and other stakeholders. - Also, planning to launch a medium of exchange within the blockchain system to allow patients to be given money for participation in the sharing of their data with the mentioned company stakeholders. - Therefore, the company stakeholders that plan to utilize the patient’s data would provide revenues and income to support the operations of the blockchain. - For example, pharmaceutical companies would be important customers that the business would cultivate as users of the patient’s healthcare data. This is because pharma companies can use this blockchain to discover patients with the right profile for a skin cancer clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. This should greatly streamline for the pharma company the time it takes to enroll the right patients into clinical trials and get them started. • Solution: - What is the core value proposition? For the company stakeholders in the skin cancer patient blockchain, the business is hoping to demonstrate that this blockchain technology will be a way to improve business outcomes through better efficiency, risk management, and security. - For these customers, this will enable them to maintain and capture new sources of profit. At the same time, company stakeholder participation will also grow the business as the integrator and host of the blockchain and result in significant profit growth for the company. • Team: The team is comprised of: - Founder, President, and CEO, a 100% full-time permanent employee has a Ph. D. in Cell and Molecular Biology from St. John’s University (New York, NY), a M. S. in Microbiology & Immunology from Long Island University, and a M. B. A. from Le Moyne College. In addition, he has 20 years of quality assurance and regulatory affairs experience at the Bristol-Myers Squibb Company, Charles Rivers Laboratories, and Vybion, Inc. This includes moving numerous human therapeutic products from R&D, through clinical trials, and into the marketplace via approval by the US FDA and worldwide regulatory bodies. In addition to the above experience, Joseph has an addition 18 year of experience in human therapeutics research and development and in the management of laboratory-based cell culture, toxicological, or bioassay projects within the biopharmaceuticals industry. However, he is a Senior Member of the food, drugs & cosmetics section of the American Society for Quality (ASQ), and a society member of The American Association for the Advancement of Science (AAAS). - The President of Hillberg Consulting is a part-time, non-permanent hourly contract employee of R&D department. She is an accomplished executive and board member with a reputation for delivering bottom-line profitability while building the infrastructure to support growth and success. She has served at Johnson & Johnson Ortho Clinical Diagnostics as VP of R&D, and as Chief Technology Officer at Carestream Health. Holly has a B. S. in Chemical Engineering from Michigan Technology University and a M. S. in Electrical Engineering from Rochester Institute of Technology. - Marketing Consultant - part-time, non-permanent hourly employee. He is a professional engineer and entrepreneurial executive with a focus on emerging technology solutions applied to real world problems. He has substantial experience in team building and in developing market strategies & partnerships. This includes over two decades of technology & networks business planning, development, & implementation. He has a Masters in Entrepreneurial Studies - MIT Sloan School of Management, and M. S. & B. S. in Engineering from Syracuse U. and Utica College. - Blockchain Development Technical Project Management Consultant - Part-time, non-permanent hourly employee that is a contractor from EffectiveSoft Corporation, San Diego, CA. She has eight years of experience as VP of Service Delivery and as the Head of Sales for enterprise level software solutions at Effective Soft Corp. She has a M. B. A. from The University of Manchester and a B. S. degree from Minsk State Linguistics U. – Legal Counsel - Part-time, non-permanent hourly contract employee. He holds the Juris Doctor from Boston College Law School, and B. A. in Political Science from Binghamton University. He is a Partner at Newman & Lickstein, with eight years of experience in representing technology companies and investors in licensing, IP development, real estate, mergers & acquisitions, and business litigation. - Demonstrating results to stakeholders will be the key to success. For skin cancer, there is a lot of data collected from various heterogeneous sources – pathology imaging data, genetic testing, surgery, drugs intervention, payer, and insurance information, etc. - Some companies are using a website or app to meet the social needs of patients to discuss their concerns with other patients or a few qualified physicians. No competitor is comprehensively focusing on skin cancer data & treatment to the level that we do. Possible competitors have thus not yet integrated the patient data, shared consent, and the patient monetization blocks together into a comprehensive and workable blockchain system for skin cancer patients, or for any segment of the oncology market, for that matter. - This team, on the other hand, has decades of experience in oncology research, the development of products and services for cancer patients, in oncology clinical biomedicine and in oncology marketing, and that makes the company well-equipped to solve the problems around skin cancer patient data acquisition, its organization, and its beneficial use for the patients and for their healthcare providers. For example, regarding the latter, the company also harnesses artificial intelligence (AI) and machine learning (ML) to extract relevant data from the patient’s database that will help healthcare providers to better understand the patient’s tumor and the tumor microenvironment (i. e. , tumor growth, cellular migration, blood supply to the tumor, subcellular trafficking, and tumor metastasis), drug efficacy (including drug penetration into the tumor, possible tumor shrinkage or tumor death, and drug toxicity, and side effects), or the immediate or long term results of surgical intervention. - When competitors enter this specific market, the business plans to stand out by utilizing a value-based strategy that clearly displays our brand and the above competitive advantage. • Traction: - Currently works with pharmaceutical and diagnostic companies, research institutes, and contract research development and manufacturing companies to help them obtain and organize their molecular bioassays and pathology data. We propose to utilize this traction and intercompany personal connections to gain and grow customers that will use and pay for patient data on the blockchain. - Also use social media & patient advocacy organization to recommend the blockchain to skin cancer patients so that we can grow the patient database. - The company is also a member of the Hyperledger Foundation Healthcare Special Interest Group. Hyperledger, as part of the Linux Foundation, provides technology leaders with a uniquely open and collaborative international community from which to develop, validate, and field enterprise-grade blockchain technology solutions. It is the mandate of the Hyperledger Healthcare Special Interest Group (HC-SIG) to represent healthcare professionals and technologists, to globally unite these individuals, and to advance the state of the healthcare industry through the implementation of technology solutions using blockchain technologies in general, and the umbrella of Hyperledger frameworks and toolsets specifically. • Revenue Model: - Within the ecosystem surrounding the above patients, who would buy/lease the skin cancer blockchain services that the company wishes to market? In this blockchain system, individuals will be allowed to store and monetize their own health data including blood test results, medical history, genetic profile, skin photographs, pathology images and other sensitive information. - In the healthcare marketplace, cancer patients would be paid in stablecoin currency to lease their individual data to companies for a certain amount of time. - Pharmaceutical (pharma) companies would be important customers that the company would cultivate as users of the patient’s permitted healthcare data. - Blockchain can help pharma companies discover patients with the right profile for a clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. - According to Milind Kamkolkar, chief data officer at Sanofi, patients could be prompted based on their data to join a clinical trial, thereby also accelerating the process and accuracy of trial recruitment. Using this blockchain if a person declines, no personal information will be shared, and the person's identity will remain private. If the person agrees, the overall process will move faster by abolishing the need for intermediaries. - For pharma companies, better inclusion in clinical trials and better reproducibility for studies can reduce the time and money needed to develop new drugs. - Besides pharma companies, research institutes will be willing to pay for the data from skin cancer patients, and the introduction of our blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely after the latter have obtained consent from individual patients. - How are the products and services going to generate revenue? The most straightforward way to generate revenue is to have the blockchain client customers pay for the products and services that exceed by a large margin what it costs to develop and operate the blockchain (a cost-plus strategy). - When competitors enter this specific market, plan to stand out by utilizing a value-based strategy that clearly displays the brand and competitive advantage. • Market Projections: - What share of the total skin cancer blockchain target market can we estimate is realistic for to obtain? The global skin cancer blockchain customer market size stood at USD 8.19 billion in 2019 and is projected to reach USD 14.55 billion by 2027, exhibiting a CAGR of 7.5% during the forecast period. A conservative estimate is that the company should be able to reach $150 million in annual revenues in 4 years. - These financial projections would be possible because of the company participating and partnering with individuals and companies within the oncology community to create superior value for the products and services. - Over the next 4 years, the company anticipates receiving funding from investors, and revenues from pharmaceutical companies and research institute customers. - However, expenditure are also expected to increase. Expenses incurred will be for the development of products and services, and for personnel, equipment, supplies, business development & marketing. • Competition: - We have identified Nebula Genomics and Longenesis as competitors. These two leading firms in artificial intelligence and blockchain technology for healthcare, are developing a platform for the storage and exchange of genomic data. - Nebula Genomics is a San Francisco-based biotechnical company that uses blockchain to “build a marketplace” for clinical genetics data. - Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group, which makes blockchain platforms for the exchange of health data. - The above companies will reportedly apply artificial intelligence and blockchain technology to develop a platform for individuals and large data providers to store, manage, exchange, and profit from genomic and other types of clinical data. To automate data acquisition, the project developed by both Nebula Genomics and Longenesis will utilize smart contracts. - Unlike the Nebula Genomics and Longenesis blockchains, this blockchain project will be focused on oncology patients and the ecosystem around them rather than on a multitude of disease sectors. - In addition to Nebula Genomics and Longenesis, the U. S. -based life science research marketplace, Scientist. com, has revealed the development of a pharmaceuticals blockchain platform. This latter blockchain-powered platform is reportedly designed to track and protect pharmaceutical data. Thus, the Scientist. com DataSmart TM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered before submission to regulators such as the FDA and the EMEA. - However, the above platforms do not adequately address the pressing concerns of cancer patients regarding the control and sharing of their personal data. Competitive Advantage: • Strategy. Specifically for oncology blockchain products, the major company players that may join our blockchain to gain access to data from skin cancer patients include: Almirall S. A. Amgen, Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company. Eli Lilly and Company. Elekta AB. F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc. Merck & Co. , Inc. Mylan NV. Novartis AG. Pfizer. Regeneron. Sanofi. Sun Pharmaceutical Industries Ltd. Varian Medical Systems, Inc. Sensus Healthcare. ICAD, Inc. Accuray, Inc.

- Business based in London, UK, is a prominent aesthetic clinic offering a range of cutting-edge treatments to help individuals enhance their appearance and boost their confidence. - The clinic has garnered a substantial client base due to its highly experienced doctors and versatile treatments. Caters to a diverse clientele seeking solutions for various aesthetic concerns. - The clinic's revenue model is driven by the provision of premium aesthetic treatments such as botox, dermal fillers, and PRP therapy, along with the most advanced technological devices. These services are in high demand and contribute significantly to the clinic's revenue stream. - The business boasts a team of skilled staff with extensive experience in aesthetic procedures. Their expertise ensures the delivery of safe and effective treatments, enhancing the clinic's reputation and attracting more clients. Runs on 3 permanent employees most of the time, but sometimes temporary employees are hired on need basis. - The clinic has also established strong relationships within the industry, collaborating with reputable medical and pharmaceutical companies to offer innovative treatments like Profhilo. These partnerships enhance the clinic's credibility and enable access to cutting-edge technologies. - The clinic boasts four treatment rooms and has demonstrated consistently high-profit margins. - The business has experienced a significant increase in annual turnover, attributed to the successful introduction of new equipment and services, which further resulted in an increase in client base. - Serves an average of 8 to 20 clients per day, with an average service value of £320. - The business holds a valid council license and insurance to practice in this industry.

- We are a gym business located in Dubai. - Currently, we cater to 120 customers. - This investment opportunity presents prospective buyers with the chance to acquire a profitable studio facility in Dubai's thriving creative landscape. - With its prime location, state-of-the-art equipment, and established client base, the studio is well-positioned for sustained growth and profitability. - The business has a trade license.

- Personal and home care brand with a comprehensive manufacturing facility offering over 120 product lines. - Diverse product portfolio including beauty soap and categories covering hair, face, and body care. - Wide range of household care products, including laundry soap, dish wash, hand wash, and various liquid detergents. - Products distributed through more than 10,000 outlets, encompassing all major supermarket chains. - International market presence with exports to continents such as Asia, Africa, and Australia. - Contract manufacturing partnerships with top global brands. - Fully certified with ISO and GMP, among other essential standards. - Established and widely recognized brand names, both locally and internationally. - Production capacity up to $1.5 million USD. - Holds necessary licenses including incorporation, ISO 9001, and GMP certifications. - Promoters possess 20 years of industry experience. - Client portfolio includes major corporations like Godrej India. - Portfolio includes 6 owned brands and partnerships with 20+ other brands. - Contract manufacturing contributes 25% of total revenue. - Own brands generate 65% of sales through retail and wholesale channels.

- Established beauty salon offering a comprehensive range of services including beauty treatments, cosmetics, skin and hair care, and bridal artistry. - Located at the present address for nearly a decade, maintaining an average daily customer count of 20 encompassing both service bookings and product purchases. - Enjoying robust support from the brand, with regular training provided to all staff and management on the latest advancements and trends within the beauty industry. - Paid a one-time franchise fee with subsequent royalties of 12% payable every 10 days. - Promoters boast 21 years of experience in the industry, ensuring seasoned expertise and knowledge. - Approximately 15,000 customers are registered with us. - Fully licensed with GST and Form C compliance in place, ensuring adherence to regulatory requirements. - Services offered span a price range from INR 450 to 15,000, catering to a diverse clientele with varied budgets and preferences.

- Clinic dealing in skin beauty and hair restoration services. - We are fully equipped with all the necessary armamentarium including Diode Qswitch Pico Laser. - We have been successfully running our practice for the last 7 years. - We have a footfall of nearly 12-15 patients every day. - The sales of the business have decreased as the doctor has multiple centres where he works. - The business has a registration certificate.

- Rated #1 commercial gym in its geography. (PIN) - Rated 4.8+ out of 5 with more than 220+ reviews. - 1,700 active memberships, 700 active floor members. - Business takes care of its expenses. - Positive cash flow, revenue, and profit-generating business. - Automated business model with lean hierarchy/org structure. - 4 streams of income: General training, personal training, specialised training, nutritional products. - Low potential risk, high margin, need-based business. - Handled single-handedly by 1 promoter currently. - The business possesses a GST certificate and all other required compliant certificates.

- Unisex salon and training academy located in Vijay Nagar which is a posh area of Indore. - The business has established a loyal customer base, with more than 110 regular clients. - The salon sees an average of 4-6 clients per day, with an average bill value is INR 500. - In addition to its salon services, the business offers beauty-related courses, with an average of 10 students per batch and 3 batches successfully completed to date. - The average course duration is 3 months, and the course fees range is INR 50,000 per student. - Majority of the revenue is from the salon services as it is a consistent channel. - The facility has 1 manicure/pedicure stations, 1 shampoo stations, 3 facial chairs, 2 facial/spa beds, 1 makeup room and 1 nail station. - Owners have over 12 years of experience in the salon business.

- Coffee brand with 3 revenue verticals. - Cafe, coffee products and gym are the 3 sources of revenue. - Revenue is primarily through cafe operations. - Recently launched direct-to-consumer (D2C) brand of coffee powders. - Gym serves as a secondary revenue stream. - We have 3 coffee bean suppliers. - Average daily cafe customers: 66. - Average order value (AOV): INR 495. - Promoters have 10 years of experience. - Licenses obtained: GST, incorporation, FSSAI. - Cafe seating capacity: 60. - Gym generates close to INR 55 lakhs/annum. - DTC coffee products are sourced, rebranded, and sold under own name. - We aim to preserve the funds generated from our ongoing operations for reinvestment into the business. Therefore, we seek external investors to provide a lump sum that can be allocated towards our marketing endeavors.